Gene · 55244
Papers1,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of Metformin on Plasma Exposure of Rifampicin, Isoniazid, and Pyrazinamide in Patients on Treatment for Pulmonary Tuberculosis. | Ther Drug Monit | 2024 | 38019456 | PubTator, text mining | PubMed |
| Hydration Methods for Cisplatin Containing Chemotherapy: A Systematic Review. | Oncologist | 2024 | 37995306 | PubTator, text mining | PubMed |
The Effect of BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma t Antagonist, Bevurogant) on the Pharmacokinetics of a Transporter Probe Cocktail, Including Digoxin, Furosemide, Metformin, and Rosuvastatin: An Open-Label, Non-randomized, 2-Period Fixed-Sequence Trial in Healthy Subjects. | Clin Pharmacol Drug Dev | 2024 | 37960990 | PubTator, text mining | PubMed |
| Bidirectional pharmacokinetic drug interactions between olaparib and metformin. | Cancer Chemother Pharmacol | 2024 | 37815561 | PubTator, text mining | PubMed |
| CcNFYB3-CcMATE35 and LncRNA CcLTCS-CcCS modules jointly regulate the efflux and synthesis of citrate to enhance aluminium tolerance in pigeon pea. | Plant Biotechnol J | 2024 | 37776153 | PubTator, text mining | PubMed |
| The lipid basis of cell death and autophagy. | Autophagy | 2024 | 37768124 | PubTator, text mining | PubMed |
| Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to "False" Decreases in Renal Function. | J Thorac Oncol | 2024 | 37748692 | PubTator, text mining | PubMed |
| Association of SLC22A1, SLC47A1, and KCNJ11 polymorphisms with efficacy and safety of metformin and sulfonylurea combination therapy in Egyptian patients with type 2 diabetes. | Res Pharm Sci | 2023 | 39005567 | PubTator, text mining | PubMed |
| Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines. | J Pharm Pharm Sci | 2023 | 38304488 | PubTator, text mining | PubMed |
| Development of a Highly Differentiated Human Primary Proximal Tubule MPS Model (aProximate MPS Flow). | Bioengineering (Basel) | 2023 | 38275575 | PubTator, text mining | PubMed |
| Current trends and future prospects of drug repositioning in gastrointestinal oncology. | Front Pharmacol | 2023 | 38239190 | PubTator, text mining | PubMed |
| Thioacetamide-Induced Acute Liver Injury Increases Metformin Plasma Exposure by Downregulating Renal OCT2 and MATE1 Expression and Function. | Biomedicines | 2023 | 38137535 | PubTator, text mining | PubMed |
| A systematic review of pregnancy-related clinical intervention of drug regimens due to pharmacokinetic reasons. | Front Med (Lausanne) | 2023 | 38093976 | PubTator, text mining | PubMed |
| DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1. | Sci Transl Med | 2023 | 38091406 | PubTator, text mining | PubMed |
| Predictors of gastrointestinal complaints in patients on metformin therapy. | Open Med (Wars) | 2023 | 38045859 | PubTator, text mining | PubMed |
| Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations. | Diabetes Metab Syndr Obes | 2023 | 38028995 | PubTator, text mining | PubMed |
| Editorial: Diabetic renal tubulointerstitial disease. | Front Endocrinol (Lausanne) | 2023 | 38027121 | PubTator, text mining | PubMed |
| Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel. | J Pharm Anal | 2023 | 38024860 | PubTator, text mining | PubMed |
| Real-Life Experience With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Turkey. | Cureus | 2023 | 38022124 | PubTator, text mining | PubMed |
| A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy. | Pharmaceutics | 2023 | 38004602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55244/papers?page=6